NanoViricides Inc. (NNVC)

[changes_iv]

From this point forward, we should see PRs that confirm progress towards Clinical Trials on 4Q 2014. Those PRs will build confidence on investors. Anticipation will build on this road to the Clinical Trials driving the pps higher, in my honest opinion.

Simultaneously testing of the FluCide drug candidates at New Mexico-based Lovelace and the UK Public Health Agency sites should result in a dataset yielding a "high degree of confidence". The FluCide drug has the potential to wipe out virtually all strains of the influenza A virus.

source: http://www.proactiveinvestors.co.uk/companies/news/57646/nanoviricides-flucide-a-potential-cure-for-the-flu-drug-to-enter-human-trials-next-year-57646.html

The BigKahuna at one time alluded to the need to see positive results on PD/PK and the LRRI, as well as UK PHE, will provide those results.

Testing for Influenza at UK PHE

Lovelace Respiratory Research Institute (LRRI)

Toxicology studies are expected to be wrapped up before mid-2014

The plan is to get the injectable version for critically-ill hospitalized patients through to the FDA drug process first, and then follow up with an application for its oral version – expected to be a much simpler process once the first approval is in hand.

source: http://www.proactiveinvestors.co.uk/companies/news/57646/nanoviricides-flucide-a-potential-cure-for-the-flu-drug-to-enter-human-trials-next-year-57646.html

I personally expect to see positive PRs from this point-in-time forward simply because we have already read them in the past. The difference now is that we will be meeting requirements from the FDA that will allow us to enter the Clinical Trials on 4Q 2014. Where are the clinical trials going to be held? That is another PR coming that will also reflect on NanoViricides, Inc. confidence in the near future (2014).

NanoViricides: RedChip Emerging Growth Showcase (June 26-27, 2013)

"...we are a company...with the ability to rapidly create drugs, and when I say rapidly create drugs I'm talking about weeks instead of years..." ~ Dr. Eugene Seymour, CEO Nanoviricides, Inc.

"by the way, I'm sure that when you think human trials for drugs you think of hundreds of millions of dollars and years of time, well in this case because the disease only lasts a week, two weeks,...that it is possible to complete human trials in the space of a few short months...four parts to the human trials" ~ Dr. Eugene Seymour, CEO Nanoviricides, Inc.